SBG — In Situ Polymerizing Peripheral Nerve Cap Class II

FDA Device Classification

FDA product code SBG covers "In Situ Polymerizing Peripheral Nerve Cap", a Class II medical device regulated under 21 CFR 882.5260. Submissions are reviewed by the Neurology panel. Devices under this code are implants. At least 2 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
SBG
Device Class
Class II
Regulation Number
882.5260
Submission Type
Review Panel
NE
Medical Specialty
Neurology
Implant
Yes

Definition

An in situ polymerizing peripheral nerve cap is a prescription use only device composed of precursor materials that polymerize when delivered to the end of a peripheral nerve to function as a physical barrier to the surrounding in vivo environment to reduce the risk of formation of a symptomatic neuroma.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K252051Tulavi Therapeuticsallay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery Tips (TL-7627Sep 29, 2025
DEN230061Tulavi Therapeuticsallay Nerve CapJul 16, 2024